Orthopedic and trauma surgeons use DermaClose to help them achieve primary
closure, avoid skin grafts and donor sites, and improve outcomes in
surgeries such as:icon3

  • Large, tissue loss injuries
  • Open fractures
  • Faciotomy repair
  • Amputation wound closure
  • Post-surgical wound infections
  • Infected hardware removal
  • Wound dehiscence
  • Post trauma (non closable wounds)

DermaClose gives plastic surgeons a tool to use their creativity when treating their challenging wounds. Many plastic surgeons have told us they use DermaClose as a creative tool. Applications include:icon2

  • Fasciotomy repair
  • ALT donor site wound closure
  • Trauma
  • Wound dehiscence
  • Oncologic excisions
  • Complex, non-healing wounds
  • Scar revisionss

From large, open abdomens to wound dehiscence, DermaClose is a proven option
for general surgeons who need an effective and fast way to close large open wounds
while avoiding skin grafts. Applications include:icon1

  • Open abdomen
  • Large skin excisions (cancer)
  • Post trauma (non-closeable wounds)
  • Wound dehiscence
  • Fasciotomy repair
  • Amputation wound closure
  • Scalp excision

DermaClose has been used extensively in foot and ankle surgery with a track record
of clinical success. Foot and ankle surgeons and podiatrists use it for:icon4

  • Diabetic foot ulcers
  • Post incision and drainage wound repair
  • Trans-metatarsal amputation (TMA)
  • Ray amputations
  • Achilles tendon repairs
  • Infected hardware removal
  • Calcenectomies
  • Scar revisions

Vascular surgeons have also used DermaClose as part of their surgical
armamentarium for:icon5

  • Lower leg bypass graft surgeries (open graft)
  • Leg vessel graft procedures (fem-pop)
  • Amputation
  • Wound dehiscence
  • Diabetic foot ulcer repair
  • Non-healing wounds

Clinical benefits

  • Reduces time to closure.
    • In a study at Walter Reed in 14 blast victims with significant tissue trauma, DermaClose achieved delayed primary closure within 4.4 days in 86% of patients in wounds averaging 263 cm squared
  • Proven in multiple surgical specialties and applications
  • Helps avoid skin grafts, donor sites, and associated risks and complications
  • Quickly becoming a standard of care for fasciotomy wounds
  • Reduces time to closure, surgical complexity, and risk of open wound complications
  • Improves surgical outcomes, cosmesis, and patient satisfaction
View Reimbursement Information Dermaclose QRG_11DR.pdf-1Download Quick Reference Guide

Case Reports